November 21, 2016 - By Richard Conner · 0 Comments
The stock of Wave Life Sciences Limited Ord (NASDAQ:WVE) registered an increase of 0.88% in short interest. WVE’s total short interest was 401,100 shares in November as published by FINRA. Its up 0.88% from 397,600 shares, reported previously. With 55,100 shares average volume, it will take short sellers 7 days to cover their WVE’s short positions. The short interest to Wave Life Sciences Limited Ord’s float is 4.03%. About 733 shares traded hands. Wave Life Sciences Ltd (NASDAQ:WVE) has risen 187.94% since April 19, 2016 and is uptrending. It has outperformed by 184.08% the S&P500.
WAVE Life Sciences Ltd. is a preclinical biopharmaceutical company. The company has a market cap of $897.97 million. The Firm focuses on developing its synthetic chemistry platform to develop and commercialize a pipeline of nucleic acid therapeutics. It currently has negative earnings. It develops nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
Out of 5 analysts covering WAVE Life Sciences (NASDAQ:WVE), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. WAVE Life Sciences has been the topic of 5 analyst reports since December 7, 2015 according to StockzIntelligence Inc. The rating was initiated by Jefferies on Monday, December 7 with “Buy”. SunTrust initiated it with “Buy” rating and $26 target price in Monday, December 7 report. The firm has “Mkt Outperform” rating by JMP Securities given on Monday, December 7. The rating was initiated by Suntrust Robinson with “Buy” on Monday, December 7. The firm earned “Outperform” rating on Monday, December 7 by Leerink Swann.
More notable recent Wave Life Sciences Ltd (NASDAQ:WVE) news were published by: Marketwatch.com which released: “WAVE Life Sciences Ltd.” on October 14, 2015, also Businesswire.com with their article: “WAVE Life Sciences Enters Collaboration with Pfizer to Develop Genetically …” published on May 05, 2016, Businesswire.com published: “WAVE Life Sciences to Present at the Jefferies 2016 London Healthcare Conference” on November 07, 2016. More interesting news about Wave Life Sciences Ltd (NASDAQ:WVE) were released by: Businesswire.com and their article: “WAVE Life Sciences to Advance Next-Generation Nucleic Acid Therapies to …” published on May 09, 2016 as well as Businesswire.com‘s news article titled: “WAVE Life Sciences Announces Plan to Deliver Six Clinical Programs by 2018” with publication date: January 29, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Richard Conner